Sickle Cell & Thalassemia Lab Support
Details
- Buyer
- NHS England
- Published
- 1 November 2023
- Submission
- 16 November 2023
- Source
- uk:atamis:dhsc
Tender description
Service to provide dedicated clinical support for antenatal and newborn haemoglobinopathy screening laboratories, and other healthcare professionals delivering the Sickle Cell and Thalassaemia Programme
Timeline
- Completed: Tender published1 November 2023Current notice
- Completed: Submission date16 November 2023
About the buyer
NHS England runs the NHS in England, and buys as a central healthcare organisation with its own team of procurement professionals. Much of this procurement flows through framework agreements and the Crown Commercial Service. Seven regional teams support the commissioning of healthcare services across the country. The central commercial function that develops procurement strategy for the whole NHS sits here.
Clinical services are commissioned directly or through the Provider Selection Regime.
Over the past 5 years, most of NHS England's contract awards have been in education and training, health and social work, and IT services.
Decision makers
Connect with the people behind this procurement.
| Contact name | Job title | Phone number | Work email |
|---|---|---|---|
| Head of Procurement | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Commercial Director | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Procurement Manager | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Category Lead | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Senior Buyer | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Contracts Manager | +44 •••• •••••• | ••••••••@nhs-england.gov |
Related buyers
Buyers similar to NHS England.
- 512£240.4m
- 437£12.4bn
- 406£109.9m
- 393£653.2m
- 325£25.1bn
- 320£1.2bn
- 296£1.6bn
- 281£3.0bn
- 156£114.3m
- 150£1.0bn
Finding public sector work shouldn't be hard
Make your next tender search effortless with Stotles. Set up alerts, find decision maker contacts and never miss a good-fit opportunity again.